151 related articles for article (PubMed ID: 37390274)
21. Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review.
Wang G; Liu Y; Zhou SF; Qiu P; Xu L; Wen P; Wen J; Xiao X
Hepatol Int; 2016 May; 10(3):501-10. PubMed ID: 26856326
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.
Wei Y; Liu J; Yan M; Zhao S; Long Y; Zhang W
Chemotherapy; 2019; 64(2):94-104. PubMed ID: 31569090
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Cao JH; Zhou J; Zhang XL; Ding X; Long QY
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
Lv XH; Wang CH; Xie Y
J Gastroenterol Hepatol; 2017 Sep; 32(9):1540-1547. PubMed ID: 28299819
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
Hung AK; Guy J
World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
[TBL] [Abstract][Full Text] [Related]
27. Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Duan R; Gong F; Wang Y; Huang C; Wu J; Hu L; Liu M; Qiu S; Lu L; Lin Y
World J Surg Oncol; 2023 Mar; 21(1):120. PubMed ID: 37004052
[TBL] [Abstract][Full Text] [Related]
28. [Network Meta-analysis of oral Chinese patent medicine for adjuvant treatment of primary liver cancer].
Zhang RR; Shao MY; Fu Y; Zhao RX; Wang JW; Li M; Zhao YX; Shao FL
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2333-2343. PubMed ID: 34047138
[TBL] [Abstract][Full Text] [Related]
29. Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
Chen X; Qiu ZK; Wang GB; Chen XL; Zhang FJ; Gao F
Diagn Interv Radiol; 2021 Sep; 27(5):671-676. PubMed ID: 34318755
[TBL] [Abstract][Full Text] [Related]
30. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review.
Xie ZB; Ma L; Wang XB; Bai T; Ye JZ; Zhong JH; Li LQ
Tumour Biol; 2014 Sep; 35(9):8451-9. PubMed ID: 25038916
[TBL] [Abstract][Full Text] [Related]
31. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
Leng JJ; Xu YZ; Dong JH
ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
Liao M; Zhu Z; Wang H; Huang J
Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
[TBL] [Abstract][Full Text] [Related]
36. Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies.
Tang YL; Qi XS; Guo XZ
Asian Pac J Cancer Prev; 2015; 16(17):7871-4. PubMed ID: 26625813
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
38. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
39. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.
Si T; Chen Y; Ma D; Gong X; Guan R; Shen B; Peng C
J Gastroenterol Hepatol; 2017 Jul; 32(7):1286-1294. PubMed ID: 28085213
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of the efficacy and safety of high-intensity focused ultrasound combined with transarterial chemoembolization and transarterial chemoembolization alone in the treatment of liver cancer.
Hu J; Mao H; He Y
Transl Cancer Res; 2022 Jun; 11(6):1678-1688. PubMed ID: 35836536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
